Circulating Humoral Factors and Endothelial Progenitor Cells in Patients With Differing Coronary Collateral Support

@article{Lambiase2004CirculatingHF,
  title={Circulating Humoral Factors and Endothelial Progenitor Cells in Patients With Differing Coronary Collateral Support},
  author={P. Lambiase and R. J. Edwards and P. Anthopoulos and S. Rahman and Y. Meng and C. Bucknall and S. Redwood and J. Pearson and M. Marber},
  journal={Circulation: Journal of the American Heart Association},
  year={2004},
  volume={109},
  pages={2986-2992}
}
Background—The mechanisms underlying the variation in collateral formation between patients, even with similar patterns of coronary artery disease, remain unclear. This study investigates whether circulating humoral or cellular factors can provide an insight into this variation. Methods and Results—Thirty patients with isolated left anterior descending coronary artery disease underwent percutaneous coronary intervention with collateral flow index (CFI) determined using a pressure wire. Patients… Expand
Humoral and cellular factors responsible for coronary collateral formation.
TLDR
The data suggest that the degree of coronary collateral formation is not determined by differences in systemically measurable levels of pro- or antiangiogenic factors assessed in this study, and cellular properties, such as cell adhesion, or genetic differences between patients may be the driving force for collateral development. Expand
Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors.
TLDR
The balance of atheroprotective and proatherosclerotic factors may influence EPC levels and their functional capacity to improve neovascularization and endothelial regeneration. Expand
Systemic and intracardiac vascular endothelial growth factor and angiopoietin‐1 and ‐2 levels in coronary artery disease: Effects of angioplasty
TLDR
There were no differences in indices of angiogenesis when aortic root, coronary ostium, coronary sinus, and femoral vein levels of VEGF and angiopoietins are compared, suggesting that peripheral blood measurements of these indices are comparable to intracardiac levels. Expand
Correlations between progression of coronary artery disease and circulating endothelial progenitor cells
  • C. Briguori, U. Testa, +10 authors G. Condorelli
  • Medicine
  • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
  • 2010
TLDR
Circulating levels of EPCs are significantly lower in patients with angiographic CAD progression, and the relationship between plasma EPC levels and the 24‐mo progression of the nonsignificant coronary artery lesion is investigated. Expand
Reduced Number of Circulating Endothelial Progenitor Cells Predicts Future Cardiovascular Events: Proof of Concept for the Clinical Importance of Endogenous Vascular Repair
TLDR
Reduced levels of circulating EPCs independently predict atherosclerotic disease progression, thus supporting an important role for endogenous vascular repair to modulate the clinical course of coronary artery disease. Expand
Relation of various plasma growth factor levels in patients with stable angina pectoris and total occlusion of a coronary artery to the degree of coronary collaterals.
We assessed (1) angiogenic factors in patients with stable angina and longstanding (> or =24 months) total occlusion of a single coronary artery and (2) the relation between plasma levels ofExpand
Circulating angiogenic cytokines and stem cells in patients with severe chronic ischemic heart disease--indicators of myocardial ischemic burden?
TLDR
Plasma concentrations of circulating stem cells and angiogenic cytokines have large inter-individual variations, which probably exclude them from being useful as indicators of myocardial ischemic burden. Expand
Endothelial progenitor cells (CD34+KDR+) and monocytes may provide the development of good coronary collaterals despite the vascular risk factors and extensive atherosclerosis.
TLDR
Endothelial progenitor cells can be mobilized from bone marrow to induce the coronary collateral growth in case of myocardial ischemia even in presence of the vascular risk factors and extensive atherosclerosis. Expand
The effect of endothelial progenitor cells on the development of collateral formation in patients with coronary artery disease.
TLDR
The findings suggested that EPC-mediated angiogenesis might be associated with coronary collateral formation in humans. Expand
Local cytokine concentrations and oxygen pressure are related to maturation of the collateral circulation in humans.
TLDR
Intravascular ischemia during brief balloon coronary occlusion is absent in human coronary collateral arteries, and the oxygen gradient found over the collateral circulation is increased in patients with a less matured collateral circulation and relates to local levels of several known pro-arteriogenic cytokines. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 33 REFERENCES
Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease
TLDR
Patients with CAD revealed reduced levels and functional impairment of EPCs, which correlated with risk factors for CAD, and hypertension was identified as a major independent predictor for impaired EPC migration. Expand
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk.
TLDR
In healthy men, levels of endothelial progenitor cells may be a surrogate biologic marker for vascular function and cumulative cardiovascular risk and suggest that endothelial injury in the absence of sufficient circulating progenitors may affect the progression of cardiovascular disease. Expand
Increase in Circulating Endothelial Progenitor Cells by Statin Therapy in Patients With Stable Coronary Artery Disease
TLDR
A novel mechanism of action of statin treatment in patients with stable CAD is defined: the augmentation of circulating EPCs with enhanced functional activity. Expand
Growth factors released into the coronary circulation after vascular injury promote proliferation of human vascular smooth muscle cells in culture.
TLDR
The change in plasma PDGF level is consistent with first-phase release of PDGF after vascular injury and the increase in mitogenicity of serum suggests that PDGF and bFGF are biologically active. Expand
Tissue factor, the emerging link between inflammation, thrombosis, and vascular remodeling.
TLDR
The importance of TF expression on the development of neointimal growth in response to hemostasis is demonstrated by demonstrating the necessity of fibrin deposition for the smooth muscle cell migration and migration in patients with unstable angina. Expand
Promotion of Collateral Growth by Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Coronary Artery Disease: A Randomized, Double-Blind, Placebo-Controlled Study
TLDR
This first clinical study investigating the potential of GM-CSF to improve collateral flow in patients with coronary artery disease documents its efficacy in a short-term administration protocol. Expand
Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: A potential predictor for the individual capacity to develop collaterals.
TLDR
The cellular response of monocytes to VEGF-A is attenuated in diabetic patients because of a downstream signal transduction defect, and data suggest that monocytes are important in arteriogenesis and that their ability to migrate might be critical to the arteriogenic response. Expand
Effects of coronary artery disease on expression and microvascular response to VEGF.
TLDR
VEGF and HGF elicit the release of nitric oxide through activation of tyrosine kinase receptors and this findings may have important implications regarding the efficacy of endogenous and exogenous VEGF in patients with risk factor for CAD. Expand
Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease.
TLDR
It is revealed that two-thirds of the patients with CAD do not have enough collateral flow to prevent myocardial ischemia during coronary occlusion, and that coronary lesion severity is the only independent pathogenetic variable related to collateral flow. Expand
Coronary Collaterals: An Important and Underexposed Aspect of Coronary Artery Disease
TLDR
The potential of individuals to develop coronary collateral circulation has so far been largely neglected but may play a major role in determining myocardial vulnerability and determinants that play a role in collateral coronary blood supply are proposed. Expand
...
1
2
3
4
...